Literature DB >> 31964693

Quantitative oculomotor and nonmotor assessments in late-onset GM2 gangliosidosis.

Christopher D Stephen1, David Balkwill2, Peter James2, Elizabeth Haxton2, Kenneth Sassower2, Jeremy D Schmahmann2, Florian Eichler2, Richard Lewis2.   

Abstract

OBJECTIVE: A cross-sectional study was performed to evaluate whether quantitative oculomotor measures correlate with disease severity in late-onset GM2 gangliosidosis (LOGG) and assess cognition and sleep as potential early nonmotor features.
METHODS: Ten patients with LOGG underwent quantitative oculomotor recordings, including measurements of the angular vestibulo-ocular reflex (VOR), with results compared to age- and sex-matched controls. Disease severity was assessed by ataxia rating scales. Cognitive/neuropsychiatric features were assessed by the cerebellar cognitive affective syndrome (CCAS) scale, Cerebellar Neuropsychiatric Rating Scale, and sleep quality evaluated using subjective sleep scales.
RESULTS: Oculomotor abnormalities were found in all participants, including 3/10 with clinically normal eye movements. Abnormalities involved impaired saccadic accuracy (5/10), abnormal vertical (8/10) and horizontal (4/10) pursuit, reduced optokinetic nystagmus (OKN) responses (7/10), low VOR gain (10/10), and impaired VOR cancellation (2/10). Compared to controls, the LOGG group showed significant differences in saccade, VOR, OKN, and visually enhanced VOR gains. Severity of saccadic dysmetria, OKN, and VOR fixation-suppression impairments correlated with ataxia scales (p < 0.05). Nine out of ten patients with LOGG had evidence of the CCAS (5/10 definite, 2/10 probable, 2/10 possible). Excessive daytime sleepiness was present in 4/10 and 8/10 had poor subjective sleep quality.
CONCLUSIONS: Cerebellar oculomotor abnormalities were present in all patients with LOGG, including those with normal clinical oculomotor examinations. Saccade accuracy (dorsal cerebellar vermis localization), fixation suppression, and OKN gain (cerebellar flocculus/paraflocculus localization) correlated with disease severity, suggesting that quantitative oculomotor measurements could be used to track disease progression. We found evidence of the CCAS, suggesting that cerebellar dysfunction may explain the cognitive disorder in LOGG. Sleep impairments were prevalent and require further study.
© 2020 American Academy of Neurology.

Entities:  

Mesh:

Year:  2020        PMID: 31964693      PMCID: PMC7176300          DOI: 10.1212/WNL.0000000000008959

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  40 in total

1.  Very late-onset Sandhoff disease presenting as Kennedy disease.

Authors:  Jodi Warman Chardon; Pierre R Bourque; Michael T Geraghty; Kym M Boycott
Journal:  Muscle Nerve       Date:  2015-12       Impact factor: 3.217

2.  Eye Movement Abnormalities Are Ubiquitous in the Spinocerebellar Ataxias.

Authors:  Christopher D Stephen; Jeremy D Schmahmann
Journal:  Cerebellum       Date:  2019-12       Impact factor: 3.847

3.  Late-onset Tay-Sachs disease.

Authors:  Andrew W Barritt; Stuart J Anderson; P Nigel Leigh; Basil H Ridha
Journal:  Pract Neurol       Date:  2017-07-24

4.  Tilt suppression of vestibulo-ocular reflex in patients with cerebellar lesions.

Authors:  T C Hain; D S Zee; B L Maria
Journal:  Acta Otolaryngol       Date:  1988 Jan-Feb       Impact factor: 1.494

5.  Measuring Friedreich ataxia: complementary features of examination and performance measures.

Authors:  D R Lynch; J M Farmer; A Y Tsou; S Perlman; S H Subramony; C M Gomez; T Ashizawa; G R Wilmot; R B Wilson; L J Balcer
Journal:  Neurology       Date:  2006-06-13       Impact factor: 9.910

Review 6.  Introduction to electronystagmography for END technologists.

Authors:  Brian A Markley
Journal:  Am J Electroneurodiagnostic Technol       Date:  2007-09

7.  Early and severe sensory loss in three adult siblings with hexosaminidase A and B deficiency (Sandhoff disease).

Authors:  H Schnorf; R Gitzelmann; N U Bosshard; M Spycher; W Waespe
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-11       Impact factor: 10.154

Review 8.  Late-onset Tay-Sachs disease presenting as catatonic schizophrenia: diagnostic and treatment issues.

Authors:  P I Rosebush; G M MacQueen; J T Clarke; J W Callahan; P M Strasberg; M F Mazurek
Journal:  J Clin Psychiatry       Date:  1995-08       Impact factor: 4.384

9.  Cerebellar Contribution to Social Cognition.

Authors:  Franziska Hoche; Xavier Guell; Janet C Sherman; Mark G Vangel; Jeremy D Schmahmann
Journal:  Cerebellum       Date:  2016-12       Impact factor: 3.847

10.  Sandhoff disease mimicking adult-onset bulbospinal neuronopathy.

Authors:  P K Thomas; E Young; R H King
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-09       Impact factor: 10.154

View more
  5 in total

1.  Natural history of Tay-Sachs disease in sheep.

Authors:  Brett Story; Toloo Taghian; Jillian Gallagher; Jey Koehler; Amanda Taylor; Ashley Randle; Kayly Nielsen; Amanda Gross; Annie Maguire; Sara Carl; Siauna Johnson; Deborah Fernau; Elise Diffie; Paul Cuddon; Carly Corado; Sundeep Chandra; Miguel Sena-Esteves; Edwin Kolodny; Xuntian Jiang; Douglas Martin; Heather Gray-Edwards
Journal:  Mol Genet Metab       Date:  2021-08-21       Impact factor: 4.204

2.  Cerebellar atrophy on top of motor neuron compromise as indicator of late-onset GM2 gangliosidosis.

Authors:  Hans Thomas Hölzer; Felix Boschann; Julia B Hennermann; Gabriele Hahn; Andreas Hermann; Maja von der Hagen; Victoria Tüngler
Journal:  J Neurol       Date:  2021-03-09       Impact factor: 4.849

3.  The CCAS-scale in hereditary ataxias: helpful on the group level, particularly in SCA3, but limited in individual patients.

Authors:  Sandra Roeske; Dagmar Timmann; Andreas Thieme; Jennifer Faber; Patricia Sulzer; Kathrin Reetz; Imis Dogan; Miriam Barkhoff; Janna Krahe; Heike Jacobi; Julia-Elisabeth Aktories; Martina Minnerop; Saskia Elben; Raquel van der Veen; Johanna Müller; Giorgi Batsikadze; Jürgen Konczak; Matthis Synofzik
Journal:  J Neurol       Date:  2022-04-01       Impact factor: 6.682

4.  The GM2 gangliosidoses: Unlocking the mysteries of pathogenesis and treatment.

Authors:  Camilo Toro; Mosufa Zainab; Cynthia J Tifft
Journal:  Neurosci Lett       Date:  2021-08-25       Impact factor: 3.046

5.  Magnetic resonance imaging and spectroscopy in late-onset GM2-gangliosidosis.

Authors:  Olivia E Rowe; D Rangaprakash; Akila Weerasekera; Neha Godbole; Elizabeth Haxton; Peter F James; Christopher D Stephen; Robert L Barry; Florian S Eichler; Eva-Maria Ratai
Journal:  Mol Genet Metab       Date:  2021-06-24       Impact factor: 4.204

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.